Uric Acid Control in Advanced CKD Uric Acid Control in Advanced CKD
Does conventional allopurinol dosing achieve adequate serum uric acid goals in advanced CKD?Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 12, 2018 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
Study: No Link Between Gout Drug, Kidney Disease
Taking the drug allopurinol to manage gout, a painful form of arthritis, is not only safe, but also potentially beneficial in reducing risk of kidney disease, researchers say. (Source: WebMD Health)
Source: WebMD Health - October 8, 2018 Category: Consumer Health News Source Type: news
Gout Drug May Protect Against Chronic Kidney Disease Gout Drug May Protect Against Chronic Kidney Disease
Allopurinol, used to manage gout, was not associated with renal function decline and may protect against development of chronic kidney disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 8, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Study Sees No Link Between Gout Drug, Kidney Disease
MONDAY, Oct. 8, 2018 -- The gout drug allopurinol may offer some protection from kidney disease, according to a new study that upends traditional beliefs.
Some doctors hesitate to prescribe the drug to patients because of concerns it may raise... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 8, 2018 Category: General Medicine Source Type: news
Allopurinol Dose Escalation for Gout Doesn't Improve Mortality
THURSDAY, Sept. 20, 2018 -- Allopurinol dose escalation is not associated with reductions in mortality risk among patients with gout, according to a study published in the August issue of Arthritis& Rheumatology.
Brian W. Coburn, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2018 Category: Pharmaceuticals Source Type: news
FREED: Febuxostat in Hyperuricemia Shields Kidneys, CV Risk Unclear FREED: Febuxostat in Hyperuricemia Shields Kidneys, CV Risk Unclear
Cardiovascular concerns about the xanthine oxidase inhibitor persist despite reassurances in the trial. Febuxostat ' s superior uric acid lowering vs allopurinol could work against it, a signal suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Daily text message may improve adherence and treatment outcomes in patients with gout
(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate significant improvements in adherence and clinical outcomes in gout patients who received a daily text message to remind them to take allopurinol. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news
Duzallo (Lesinurad and Allopurinol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 7, 2018 Category: Drugs & Pharmacology Source Type: news
Adding Allopurinol Safe, Effective in IBD (CME/CE)
(MedPage Today) -- Option for those with thiopurine hypermethylation (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 20, 2018 Category: Gastroenterology Source Type: news
Allopurinol: Extra Caution Urged in High-Risk Groups Allopurinol: Extra Caution Urged in High-Risk Groups
The risk for severe cutaneous adverse reactions to allopurinol was much higher among those who were black, Asian, Native Hawaiian/Pacific Islander, women, older, or receiving higher starting doses.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Ethnicity Matters in Allopurinol Reactions (CME/CE)
(MedPage Today) -- Blacks, Asians, and Native Hawaiians had greater risk of severe cutaneous reactions than did whites/Hispanics (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 17, 2018 Category: Primary Care Source Type: news
Allopurinol/lesinurad cost effective for gout/hyperuricaemia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news
CARES Hints Mortality Risk in CV Patients on Gout Med Febuxostat CARES Hints Mortality Risk in CV Patients on Gout Med Febuxostat
The mortality signal was something of a mystery as a secondary result. Febuxostat was primarily ' noninferior ' to allopurinol for safety in the patients with a history of cardiovascular disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 13, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Does Dose Escalation Help in Gout?
(MedPage Today) -- Given the way allopurinol is used, the question can ' t really be answered (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 13, 2018 Category: Primary Care Source Type: news
One Gout Medication Comes Out on Top for CV Risk
(MedPage Today) -- Allopurinol the loser in retrospective comparison of two drugs (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 26, 2018 Category: Cardiology Source Type: news
